Advertisement
Screener

EQUILLIUM, INC. (EQ) Proceeds from Convertible Debt

2.8 / 5 stars · 68/120 Roast Me

EQUILLIUM, INC. Proceeds from Convertible Debt

EQUILLIUM, INC. (EQ) reported Proceeds from Convertible Debt of $1.60 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-26.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromConvertibleDebt · last filed 2020-03-26

  • EQUILLIUM, INC. proceeds from convertible debt for the quarter ending 2018-12-31 was $0.00.
  • EQUILLIUM, INC. proceeds from convertible debt for the quarter ending 2018-09-30 was $0.00.
  • EQUILLIUM, INC. proceeds from convertible debt for fiscal 2018 was $1.60M.
Period endProceeds from Convertible Debt 3 monthProceeds from Convertible Debt 6 monthProceeds from Convertible Debt 9 monthProceeds from Convertible Debt 9 month as first filedProceeds from Convertible Debt 10 monthProceeds from Convertible Debt 12 monthProceeds from Convertible Debt 12 month as first filed
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$0.00
derived: sum of 2 quarters · filed 2020-03-26
$1.60M
10-K · filed 2020-03-26
$1.60M
10-K · filed 2019-03-27
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.60M
10-Q · filed 2019-11-12
$1.60M
10-Q · filed 2018-11-15
2018-06-30$1.60M
10-Q · filed 2019-08-12
2017-12-31$6.77M
10-K · filed 2019-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
GENELUX Corp (GNLX)United States$0.110B-3.83
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49